SCHEMBL1446463

SCHEMBL1446463

CC(C)C[Si](C)(C)OCc1cncn1Cc1ccccc1C#N

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.41
CYP11B1 P15538 2/20 0.39
CYP11B2 P19099 2/20 0.39
TSHR P16473 1/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
FNTA P49354 2/20 0.37
FNTB P49356 2/20 0.37
PGGT1B P53609 2/20 0.37
BRD4 O60885 1/20 0.35
GALR3 O60755 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5037113 0.84 CYP19A1 (0.40) CYP19A1CYP11B1CYP11B2TSHRALDH1A1
SCHEMBL1097299 0.82 CYP19A1 (0.42) CYP19A1CYP11B1CYP11B2ALDH1A1MAPT
SCHEMBL12820668 0.75 CYP11B1 (0.58) CYP19A1CYP11B1CYP11B2TSHRALDH1A1
SCHEMBL1096475 0.74 CYP19A1 (0.41) CYP19A1CYP11B1CYP11B2TSHRALDH1A1
SCHEMBL8441652 0.73 CYP19A1 (0.49) CYP19A1CYP11B1CYP11B2TSHRALDH1A1
SCHEMBL8359571 0.70 CYP19A1 (0.46) CYP19A1CYP11B1CYP11B2TSHRALDH1A1
SCHEMBL27855265 0.70 CYP11B1 (0.48) CYP19A1CYP11B1CYP11B2ALDH1A1MAPT
Hydrochloric Acid SCHEMBL7847528 0.68 CYP19A1 (0.52) CYP19A1CYP11B1CYP11B2TSHRALDH1A1
SCHEMBL1950222 0.67 CYP11B1 (0.63) CYP19A1CYP11B1CYP11B2ALDH1A1MAPT
SCHEMBL1097298 0.65 CYP19A1 (0.41) CYP19A1CYP11B1CYP11B2TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2301931-B1 IMIDAZOLES AS ALDOSTERONE SYNTHASE INHIBITORS NOVARTIS AG (CH) 2013-10-16 EP disclosed
EP-2301931-A1 Imidazoles as aldosterone synthase inhibitors Novartis AG (CH) 2011-03-30 EP disclosed